Short Communication
Ann Hematol Oncol. 2019; 6(6): 1255.
Demographic Profile, Etiology of Reactive Thrombocytosis and Its Association with Anemia in North East India
Mishra Narain Mahendra¹* and Bhuyan A²
¹Department of Pathology, Baptist Christian Hospital, India
²Department of Pediatrics, Baptist Christian Hospital, India
*Corresponding author: Mishra Narain Mahendra, Department of Pathology, Baptist Christian Hospital, Tezpur, Assam, India
Received: April 22, 2019; Accepted: June 13, 2019;Published: June 20, 2019
Abstract
Reactive thrombocytosis is often observed in response to iron deficiency anemia, acute infections, chronic inflammatory diseases including rheumatoid arthritis, hemorrhage and sometimes in cancer. Sixty - eight non-consecutive cases of reactive thrombocytosis that visited a secondary care hospital in North East India were studied to analyse the demographic profile, aetiology and association with anemia which is very common in this population.
Keywords: Reactive thrombocytosis; anemia; North East India; demography
Introduction
This retrospective study was carried out in a secondary care centre in North –East India to study the etiology, demographic profile, relationship with anemia of patients identified to have reactive thrombocytosis (Platelet count > 500,000/μl) and whether it could be used as a marker of inflammation in absence of neutrophilia.
Methods
Two milliliters of EDTA blood was collected through a clean venipuncture from 68 non – consecutive. The samples were tested twice; in a Sysmex XS 800 I Haematology Analyser followed by in Sysmex KX21 3 part Haematology Cell analyser and correlated on peripheral blood smear.
Results
There was a slight male preponderance (n=36 – 52.9%). Mean age of the patients was 16.2 years (range 3 months -80 years) of which there were 50 children (73.5%). Platelet counts ranged from 507,00 – 1,290,000/μl with mean of 696,000/μl. Seven patients (10.2%) had extreme thrombocytosis (counts > 1,000,000/μl) as per the classification used by Chirello. et al [1]. Fifty-three (77.9%) patients were anemic (Haemoglobin range 3.4 -13.2 gm/deciliter (gm/dl) (normal > 11 gm/dl. Leukocytosis was present in 44 (64.7%) patients. Mean Total Leukocyte Count (TLC) was 19, 800/μl with range 5900 -52,600/μl. Neutrophilia was seen in 42 (61.8%), lymphocytosis in seven (10.3%) and more than one cell type in four patients. Aetiological classification of patients is shown in (Table 1).
Respiratory tract infections
22
Pneumonia
3
Chronic Obstructive Pulmonary Disease
1
Empyema
1
Chronic Kidney disease
3
Nephrotic Syndrome
2
Acute Glomerulonephritis
2
Acute Renal failure
1
Acute gastroenteritis
5
Acute gastritis
1
Necrotizing pancreatitis
1
Lymphadenitis (mesenteric and supraclavicular)
2
Polyarthritis (1 juvenile)
2
Tuberculosis
(spine -3, military 1, lung 1, intestine 1)
6
Microcytic Hypochromic Anemia
2
Sepsis
2
Abscess
2
Orthopedics (2 fractures, 1 hip dislocation)
3
Developmental delay
2
Incomplete abortion
1
Carcinoma Rectum
1
Organophosphorus poisoning
1
Drowning
1
Kernicterus
1
Table 1: Causes of Reactive Thrombocytosis in 68 patients.
Follow-up
One patient with metabolic encephalopathy died within a day of admission, three patients were referred and two left against medical advice. The remaining patients were treated in the hospital and have recovered.
Discussion
This study included a wide spectrum of cases which were found to have Reactive Thrombocytosis (RT). There was no correlation between severity of thrombocytosis and anemia as has been described by some authors [2,3]. Extreme RT has been reported in less than 2-3 % of patients [4]. All seven patients with extreme RT in this study had an infectious cause. None of the patients had a complication related to thrombocytosis and all improved on treatment of underlying cause. Yohnan et al. in a study involving 663 patients detected hyper RT (counts >1,000,000/μl) in 2% of the children [5]. In this study four children (8%) had platelet counts exceeding 1,000,000/ μl; higher frequency could be attributed to the small population studied and selection. Fifty –three patients had anemia along with thrombocytosis and many of them also had a focus of infection. In a study by Subramaniam et al. Anemia with coexistent infection was the commonest cause of thrombocytosis as was observed in this study also [3]. Possible mechanisms of thrombocytosis include raised levels of cytokines, such as Interleukin (IL)-6, IL-1, and Tumor Necrosis Factor (TNF), have been shown to promote in vivo and in vitro megakaryocytopoiesis [6]. However, thrombopoietin is the principal regulator of megakaryocytopoiesis [7-9]. Eleven patients with RT, of which six were anemic had normal leukocyte counts. In these patients RT was a marker for infection /inflammation. Another significant finding was that nearly a – third of the patients which included six adults and 19 children with fever had thrombocytosis as the sole abnormality. It is therefore suggested that thrombocytosis alone could be an important marker of inflammation.
References
- Chiarello P, Magnolia M, Rubino M, Liguori SA, Miniero R. Thrombocytosis in children. Minerva Pediatr. 2011; 63: 507–513.
- Soto AF, Ford P, Mastoris J. Thrombocytosis in Iron Deficiency Anemia: What the Primary Care Physician Needs To Know. Blood. 2006; 108: 3723.
- Subramaniam N, Mundkur S, Kini P, Bhaskaranand N, Aroor S. “Clinicohematological Study of Thrombocytosis in Children”. ISRN Hematology. 2014.
- Dame C, Sutor AH. Primary and secondary thrombocytosis in childhood. Br J Haematol. 2005; 129: 165-177.
- Yohannan MD, Higgy KE, al-Mashhadani SA, Santhosh-Kumar CR. Thrombocytosis, Etiologic analysis of 663 patients Clin Pediatr (Phila). 1994; 33: 340-343.
- Dan K, Gomi S, Inokuchi K. Effects of interleukin-1 and tumor necrosis factor on megakaryocytopoiesis: mechanism of reactive thrombocytosis. Acta Haematol. 1995; 93: 67-72.
- Lok S, Kaushansky K, Holly RD. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature. 1994; 369: 565-568.
- de Sauvage FJ, Hass PE, Spencer SD. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature. 1994; 369: 533-538.
- Kaushansky K, Lok S, Holly RD. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature. 1994; 369: 568-571.